These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7271895)

  • 21. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
    Savasta M; Dubois A; Scatton B
    Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation by ATP of [3H]dopamine binding to synaptic membrane fractions of canine caudate nucleus.
    Sano K; Maeno H
    Biochem Biophys Res Commun; 1976 Dec; 73(3):584-90. PubMed ID: 1008875
    [No Abstract]   [Full Text] [Related]  

  • 23. Polyenoic fatty acid deprivation of juvenile cats modulates 3H-dopamine release from presynaptic receptors in caudate slices.
    Davidson BC; Cantrill RC; Kurstjens NP; Patton J
    In Vivo; 1988; 2(3-4):295-8. PubMed ID: 2979846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors.
    Creese I; Padgett L; Fazzini E; Lopez F
    Eur J Pharmacol; 1979 Jul; 56(4):411-2. PubMed ID: 477735
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased dopamine-receptor sensitivity in schizophrenia.
    Owen F; Cross AJ; Crow TJ; Longden A; Poulter M; Riley GJ
    Lancet; 1978 Jul; 2(8083):223-6. PubMed ID: 79025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presynaptic and postsynaptic D1 dopamine receptors in the nigrostriatal system of the rat brain: a quantitative autoradiographic study using the selective D1 antagonist [3H]SCH 23390.
    Filloux FM; Wamsley JK; Dawson TM
    Brain Res; 1987 Apr; 408(1-2):205-9. PubMed ID: 2954613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat.
    Nieoullon A; Cheramy A; Glowinski J
    Brain Res; 1978 Jun; 148(1):143-52. PubMed ID: 656921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
    Köhler C; Hall H; Ogren SO; Gawell L
    Biochem Pharmacol; 1985 Jul; 34(13):2251-9. PubMed ID: 4015674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine.
    Feuerstein TJ; Hertting G; Lupp A; Neufang B
    Br J Pharmacol; 1986 Jul; 88(3):677-84. PubMed ID: 3742155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D1 and D2 receptor selectivities of agonists and antagonists.
    Seeman P; Ulpian C
    Adv Exp Med Biol; 1988; 235():55-63. PubMed ID: 2976254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
    Wreggett KA; Seeman P
    Mol Pharmacol; 1984 Jan; 25(1):10-7. PubMed ID: 6231467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.
    Wagner GC; Ricaurte GA; Seiden LS; Schuster CR; Miller RJ; Westley J
    Brain Res; 1980 Jan; 181(1):151-60. PubMed ID: 7350950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective labeling of apomorphine receptors by 3H-LSD.
    Whitaker PM; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
    Sumiyoshi T; Stockmeier CA; Overholser JC; Thompson PA; Meltzer HY
    Brain Res; 1995 May; 681(1-2):109-16. PubMed ID: 7552267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug interactions with the dopamine transporter in cryopreserved human caudate.
    Eshleman AJ; Wolfrum K; Mash DC; Christensen K; Janowsky A
    J Pharmacol Exp Ther; 2001 Feb; 296(2):442-9. PubMed ID: 11160629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation.
    Joyce JN; Loeschen SK; Marshall JF
    Brain Res; 1985 Jul; 338(2):209-18. PubMed ID: 3161583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.